A detailed history of Fort Point Capital Partners LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Fort Point Capital Partners LLC holds 688 shares of VRTX stock, worth $282,527. This represents 0.04% of its overall portfolio holdings.

Number of Shares
688
Previous 530 29.81%
Holding current value
$282,527
Previous $248,000 28.63%
% of portfolio
0.04%
Previous 0.03%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $72,680 - $79,913
158 Added 29.81%
688 $319,000
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $5,892 - $7,282
-15 Reduced 2.75%
530 $248,000
Q4 2023

Feb 09, 2024

BUY
$343.0 - $410.68 $186,935 - $223,820
545 New
545 $221,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Fort Point Capital Partners LLC Portfolio

Follow Fort Point Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Point Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Point Capital Partners LLC with notifications on news.